If you are pregnant, trying to conceive, breastfeeding, taking medication, undergoing fertility treatment (IVF, IUI, ICSI), or under medical supervision, consult your doctor before use
We take a personalized approach to each patient, creating tailored plans that address individual goals and needs
References Journal of Endocrinology & Metabolism (2014) Safety and metabolism of AOD9604: novel nutraceutical ingredient for improved metabolic health Journal of Clinical Endocrinology & Metabolism (PubMed) Prolonged stimulation of GH and IGF-I secretion by CJC-1295 in healthy adults European Journal of Endocrinology (PubMed) Ipamorelin: the first selective growth hormone secretagogue Translational Andrology and Urology (PMC) Role of growth hormone secretagogues in body composition management Endocrinology (OUP) hGH and AOD-9604: lipid metabolism and beta-adrenergic pathway insights CDC Preventing unsafe injection practices: multi-dose vial handling guidelines Journal of Endocrinology & Metabolism (2013) Safety and tolerability of the hexadecapeptide AOD9604 in humans Obesity Pharmacotherapy Review (PMC) AOD-9604 clinical trial overview and weight loss outcomes Subcutaneous Drug Injection Review (PMC) Pharmacologic considerations of the subcutaneous route CDC Vaccine administration: subcutaneous route (angle/site guidance) MedlinePlus Subcutaneous injections: patient instructions and technique NCBI Bookshelf Best practices for injection: asepsis, preparation, and administration Additional Research and Background These sources provide related context and are not presented as support for a specific statement above
Early disseminated Lyme disease: Cardiac manifestations
If you travel frequently or have an unpredictable schedule, a morning injection can be easier to remember on the same day each week
Scientific References Type 2 diabetes in adults: management (NG28)
